19 May 2013
Keywords: az, gets, nod, eu, new, atacand, doses
Article | 16 February 2009
Anglo-Swedish drug major AstraZeneca has received European approval for two new dose strengths of its the angiotensin receptor blocker Atacand
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 February 2009
17 May 2013
© 2013 thepharmaletter.com